Communication Training for Caregivers In Advanced Care Planning

Completed

• Conditions: Advanced Care Planning; Primary Malignant Brain Tumors

• Registration Number: NCT04171895
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The purpose of this research study is to develop and test a new communication training to help caregivers communicate more effectively with their loved ones and healthcare professionals about advanced care planning.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-11-19
• Study First Submitted: 2019-11-19
• Study First Submitted QC: 2019-11-19
• Study First Posted: 2019-11-21
• Status Verified: 2024-08
• Primary Completion: 2024-08-22
• Study Completion: 2024-08-22
• Last Update Submitted: 2024-08-23
• Last Update Posted: 2024-08-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 49

Inclusion Criteria

Part 1:

Informal caregivers:

• Current self-reported informal cancer caregivers (IC) to a patient with a primary malignant brain tumor as per clinician judgment or as per EMR
• English fluency: Self-report by participant identifying English as the preferred language for healthcare, and self-reported degree of fluency as speaking English "Very well."
• age ≥ 18
• has access to a computer or smartphone with a webcam and internet connection

Patients:

• English-speaking as per EMR
• Able to provide informed consent, a determination that will be made in assistance with the patient's medical team.

Part II:

Informal caregivers:

• Current self-reported IC to an MSK patient with a (1) primary malignant brain tumor or (2) leptomeningeal metastasis of a solid tumor, as per clinician judgment or as per EMR.
• English fluency: Self-report by identifying English as the preferred language for healthcare, and self-reported degree of fluency as speaking English "Very well."
• Age >18 as per self report
• Access to a computer or smartphone with a webcam and internet connection as per self report

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
preliminary efficacy	1 year	Feasibility criteria will be met if the target number of participants (n=10) complete a training session within the planned timeframe.

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States